×

Immunotherapy using interleukin 13 receptor subunit alpha 2

  • US 20020197266A1
  • Filed: 02/08/2001
  • Published: 12/26/2002
  • Est. Priority Date: 02/08/2000
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for stimulating a immune response against IL-13Rα

  • 2 in a subject having or at risk for developing a disease having cells expressing IL-13Rα

    2, the method comprising the steps of;

    (a) formulating an anti-cancer vaccine outside of the subject, the vaccine comprising an agent that can stimulate an immune response against IL-13Rα

    2 when administered to an animal; and

    (b) administering the vaccine to the subject in an amount sufficient to stimulate an immune response against IL-13Rα

    2 in the subject.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×